Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2009-07-29

EMA Expired: Procomvax (polyribosylribitol phosphate from Haemophilus influenzae type b as PRP-OMPC;outer membrane protein complex of Neisseria meningitidis (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B);adsorbed hepatitis B surface antigen produced in recombinant yeast cells (Saccharomyces cerevisiae)) — Sanofi Pasteur MSD, SNC

View source ↗

Summary

The EMA indicates that Procomvax, a combination vaccine for hepatitis B and meningitis Haemophilus influenzae type b, has expired (product status withdrawn).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Procomvax

Snippet

Status: Expired. Therapeutic area: Hepatitis B;Meningitis, Haemophilus;Immunization. MAH: Sanofi Pasteur MSD, SNC. Decision date: 11/12/2007